Potential use of ipatropium bromide for the treatment of clozapine-induced hypersalivation: A preliminary report

International Clinical Psychopharmacology

Volumn 15, Issue 1, 2000, Pages 49-52

  Calderon, Jose ^a   Rubin, Eugene ^a   Sobota, Walter L ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Clozapine; Clozapine induced sialorrhea; Drooling; Hypersalivation; Ipatropium bromide

Indexed keywords

BENZATROPINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; CLOZAPINE; IPRATROPIUM BROMIDE; NEUROLEPTIC AGENT;

ADULT; ANTICHOLINERGIC EFFECT; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; HYPERSALIVATION; MALE; PRIORITY JOURNAL; RATING SCALE; SIDE EFFECT;

EID: 0033954425     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200015010-00008     Document Type: Article

References (19)

1. Afshar M, Rubin E (1999) Clozapine, psychiatry/primary care interface. Prim Care Psychiatry 6:90-104.
2. Ben-Aryeh H, Jungerman T, Szargel R (1996) Salivary flow-rate and composition in schizophrenic patients on clozapine: subjective reports and laboratory data. Biol Psychiatry 39:946-949.
3. Brodkin ES, Pelton G, Price LH (1996) Letter to the editor: treatment of clozapine-induced parotid gland swelling. Am J Psychiatry 153:445.
4. Buckley PF, Schulz SC (1996) Clozapine and risperidone refining and extending their use. Harvard Rev Psychiatry 4:184-196.
5. Buckley PF (1997) New dimensions in the pharmacologic treatment of schizophrenia and related psychoses. J Clin Pharmacol 37:363-378.
6. Conry A, Siris SG, Bermanzohn PC (1996) Letter to the editor: improvement of clozapine-induced sialorrhea after septoplasty. Am J Psychiatry 153:444.
7. Corrigan FM, MacDonald S (1995) Letter to the editor: clozapine-induced hypersalivation and the alpha-2 adrenoreceptor. Br J Psychiatry 167:412.
8. Grabowski J (1992) Clonidine treatment of clozapine-induced hypersalivation. Lancet 346:1034.
9. Hinkes R, Quesada T, Currier MB (1996) Letter to the editors: aspiration pneumonia possibly secondary to clozapine-induced sialorrhea. J Clin Psychopharmacol 16:462-463.
10. Honigfeld G, Arellano F, Sethi J, Bianchini A, Schein J. (1998) Reducing Clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry. J Clin Psych 59 (Suppl 3):3-7.
11. Jurgen F, Tilmann E (1995) Letter to the editors: pirenzepine for clozapine-induced hypersalivation. Lancet 346:1034.
12. Lieberman JA, Safferman AZ, Pallaer S (1994) Clinical effects of clozapine in chronic schizophrenia, response to treatment and predictors of outcome. Am J Psychiatry 151:1744-1752.
13. Perkins DO, Lieberman JA (1998) Medical complications and selectivity of therapeutic response to atypical antipsychotic drugs. Am J Psychiatry 155:272-276.
14. Rabinowitz T, Frankenburg FR, Centorrino F (1996) The effect of clozapine on saliva flow rate: a pilot study. Biol Psychiatry 40:1132-1134.
15. Robinson D, Fenn H, Yesavage J (1995) Letter to the editor: possible association of parotiditis with clozapine. Am J Psychiatry 152:297-298.
16. Siegel S (1956) The Sign test. In: Nonparametric Statistics for the Behavioral Sciences (Siegal S, ed.) New York: McGraw Hill Book Co, pp. 68-75.
17. Spivak B, Adlesberg S, Rosen L (1997) Trihexyphenidyl treatment of clozapine-induced hypersalivation. Int Clin Psychopharmacol 12:213-215.
18. Szabadi E (1996) Letter to the editor: clozapine induced hypersalivation and the alpha-2 adrenoreceptor. Br J Psychiatry 169:380-381.
19. Szabadi E (1997) Letter to the editor: clozapine induced hypersalivation. Br J Psychiatry 171:89.